Molecular Regulation in Dopaminergic Neuron Development. Cues to Unveil Molecular Pathogenesis and Pharmacological Targets of Neurodegeneration

Int J Mol Sci. 2020 Jun 3;21(11):3995. doi: 10.3390/ijms21113995.

Abstract

The relatively few dopaminergic neurons in the mammalian brain are mostly located in the midbrain and regulate many important neural functions, including motor integration, cognition, emotive behaviors and reward. Therefore, alteration of their function or degeneration leads to severe neurological and neuropsychiatric diseases. Unraveling the mechanisms of midbrain dopaminergic (mDA) phenotype induction and maturation and elucidating the role of the gene network involved in the development and maintenance of these neurons is of pivotal importance to rescue or substitute these cells in order to restore dopaminergic functions. Recently, in addition to morphogens and transcription factors, microRNAs have been identified as critical players to confer mDA identity. The elucidation of the gene network involved in mDA neuron development and function will be crucial to identify early changes of mDA neurons that occur in pre-symptomatic pathological conditions, such as Parkinson's disease. In addition, it can help to identify targets for new therapies and for cell reprogramming into mDA neurons. In this essay, we review the cascade of transcriptional and posttranscriptional regulation that confers mDA identity and regulates their functions. Additionally, we highlight certain mechanisms that offer important clues to unveil molecular pathogenesis of mDA neuron dysfunction and potential pharmacological targets for the treatment of mDA neuron dysfunction.

Keywords: Parkinson’s disease; dopamine; microRNAs; midbrain; morphogens; transcription factors.

Publication types

  • Review

MeSH terms

  • Animals
  • Brain / metabolism
  • Cell Differentiation
  • Dopamine / metabolism*
  • Dopaminergic Neurons / metabolism*
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Gene Expression Regulation, Developmental
  • Humans
  • Mesencephalon / metabolism
  • Mesencephalon / pathology
  • MicroRNAs / metabolism
  • Neurodegenerative Diseases / drug therapy
  • Neurodegenerative Diseases / metabolism*
  • Neurogenesis / genetics
  • Parkinson Disease / pathology
  • Phenotype
  • Regenerative Medicine
  • Transcription Factors / metabolism

Substances

  • MicroRNAs
  • Transcription Factors
  • Extracellular Signal-Regulated MAP Kinases
  • Dopamine